IOVA (Iovance Biotherapeutics, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

Iovance Biotherapeutics, Inc. Common Stock (IOVA) is a publicly traded Healthcare sector company. As of May 21, 2026, IOVA trades at $3.54 with a market cap of $1.51B and a P/E ratio of -1.86. IOVA moved +2.02% today. Year to date, IOVA is +44.49%; over the trailing twelve months it is +85.34%. Its 52-week range spans $1.64 to $12.51. Analyst consensus is buy with an average price target of $8.44. Rallies surfaces IOVA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns IOVA stock?

Hedge funds tracked by Rallies that own IOVA include Orbimed Advisors, Panagora Asset, and Farallon Capital. The latest tracked quarter is Dec 31, 2023. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Iovance Biotherapeutics, Inc. Common Stock.

IOVA Key Metrics

Key financial metrics for IOVA
MetricValue
Price$3.54
Market Cap$1.51B
P/E Ratio-1.86
EPS$-1.89
Dividend Yield0.00%
52-Week High$12.51
52-Week Low$1.64
Volume21
Avg Volume0
Revenue (TTM)$1.19M
Net Income$-444.04M
Gross Margin-804.54%

Top Hedge Funds Holding IOVA

  • Orbimed Advisors holds 4.71M shares of IOVA, changed +0.00% as of Dec 31, 2023.
  • Panagora Asset holds 215.00K shares of IOVA, changed -26.39% as of Dec 31, 2024.
  • Farallon Capital holds 26.00K shares of IOVA, changed +0.00% as of Mar 31, 2026.

Latest IOVA News

Recent IOVA Insider Trades

  • Kirby Daniel Gordon bought 30.00K (~$55.20K) on Jun 5, 2025.
  • Puri Raj K. bought 5.60K (~$9.74K) on May 23, 2025.
  • Vogt Frederick G bought 25.00K (~$42.25K) on May 14, 2025.

IOVA Analyst Consensus

10 analysts cover IOVA: 0 strong buy, 7 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $8.44.

Common questions about IOVA

Who owns IOVA stock?
Hedge funds tracked by Rallies that own IOVA include Orbimed Advisors, Panagora Asset, and Farallon Capital. The latest tracked quarter is Dec 31, 2023. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Iovance Biotherapeutics, Inc. Common Stock.
Does Rallies show 13F holders for IOVA?
Yes. Rallies tracks hedge fund and 13F ownership data for IOVA, including fund names, share counts, latest tracked quarter, and position changes when available.
Is IOVA research on Rallies investment advice?
No. Rallies provides research, data, and educational context for IOVA. It does not provide personalized investment advice.
IOVA

IOVA